Randall J Basaraba Selected Research

Aerosols

6/2015	Presence of multiple lesion types with vastly different microenvironments in C3HeB/FeJ mice following aerosol infection with Mycobacterium tuberculosis.
6/2012	Evaluation of a mouse model of necrotic granuloma formation using C3HeB/FeJ mice for testing of drugs against Mycobacterium tuberculosis.
1/2012	Non-diabetic hyperglycemia exacerbates disease severity in Mycobacterium tuberculosis infected guinea pigs.
9/2011	Mycobacterium bovis BCG-mediated protection against W-Beijing strains of Mycobacterium tuberculosis is diminished concomitant with the emergence of regulatory T cells.
6/2011	Vaccination of guinea pigs using mce operon mutants of Mycobacterium tuberculosis.
5/2011	Cigarette smoke increases susceptibility to tuberculosis--evidence from in vivo and in vitro models.
1/2011	Immune Responses of HIV-1 Tat Transgenic Mice to Mycobacterium Tuberculosis W-Beijing SA161.
5/2009	Clinical strains of Mycobacterium tuberculosis display a wide range of virulence in guinea pigs.
4/2009	Immune response to Mycobacterium tuberculosis and identification of molecular markers of disease.
3/2009	Post-exposure vaccination against Mycobacterium tuberculosis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Randall J Basaraba Research Topics

Disease

44	Tuberculosis (Tuberculoses) 04/2022 - 11/2002
40	Infections 04/2022 - 11/2002
12	Granuloma 04/2022 - 11/2002
9	Necrosis 06/2015 - 04/2003
6	Inflammation (Inflammations) 01/2015 - 10/2006
5	Pulmonary Tuberculosis 06/2015 - 02/2003
3	Rhinosinusitis 10/2018 - 11/2012
3	Pneumonia (Pneumonitis) 03/2009 - 08/2005
2	Glucose Intolerance 10/2020 - 01/2017
2	Insulin Resistance 10/2020 - 01/2012
2	Type 2 Diabetes Mellitus (MODY) 01/2017 - 04/2014
2	Hyperglycemia 01/2017 - 01/2012
2	Persistent Infection 04/2014 - 09/2011
2	Latent Tuberculosis 05/2007 - 04/2003
2	Chronic Disease (Chronic Diseases) 06/2005 - 08/2003
1	Neoplasms (Cancer) 01/2021
1	Carcinogenesis 01/2021
1	Nontuberculous Mycobacterium Infections 01/2020
1	Noncommunicable Diseases 03/2016
1	Diabetes Complications 01/2015
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 08/2014
1	Sinusitis 05/2014
1	Edema (Dropsy) 05/2014
1	Nasal Polyps (Nasal Polyp) 05/2014
1	Hypersensitivity (Allergy) 02/2013
1	Hypoxia (Hypoxemia) 06/2012
1	Bovine Tuberculosis 01/2012
1	Anemia 11/2011

Drug/Important Bio-Agent (IBA)

23	AerosolsIBA 06/2015 - 04/2003
15	Pharmaceutical PreparationsIBA 01/2021 - 08/2007
13	VaccinesIBA 01/2021 - 04/2003
10	Proteins (Proteins, Gene)FDA Link 01/2017 - 11/2002
6	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 11/2012
4	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 04/2014
4	CytokinesIBA 04/2014 - 10/2006
4	DNA (Deoxyribonucleic Acid)IBA 04/2014 - 04/2003
3	Interleukin-10 (Interleukin 10)IBA 04/2014 - 06/2005
3	Tuberculosis VaccinesIBA 02/2012 - 02/2003
3	BCG Vaccine FDA Link 06/2011 - 01/2006
2	Metformin (Glucophage)FDA LinkGeneric 10/2020 - 01/2017
2	CarbohydratesIBA 01/2017 - 04/2014
2	Streptozocin (Streptozotocin)FDA Link 01/2017 - 04/2014
2	Advanced Glycation End ProductsIBA 01/2015 - 01/2012
2	ChemokinesIBA 04/2014 - 08/2003
2	InterferonsIBA 04/2014 - 01/2012
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 04/2014 - 08/2003
2	Rifampin (Rifampicin)FDA LinkGeneric 02/2012 - 01/2011
2	AntigensIBA 01/2012 - 02/2009
2	Biological ProductsIBA 01/2012 - 05/2011
2	Malondialdehyde (Propanedial)IBA 01/2012 - 01/2011
2	AntioxidantsIBA 01/2012 - 01/2011
2	IronIBA 11/2011 - 01/2008
2	bedaquiline (R207910)IBA 01/2011 - 09/2007
2	AcidsIBA 05/2010 - 09/2007
2	OvalbuminIBA 03/2009 - 11/2002
1	Vitamin A (Retinol)FDA LinkGeneric 04/2022
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2021
1	senexin AIBA 01/2020
1	HexokinaseIBA 01/2020
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2020
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2020
1	Detergents (Detergent)IBA 01/2017
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2017
1	Glipizide (Glucotrol)FDA LinkGeneric 01/2017
1	Nucleic AcidsIBA 01/2017
1	Coloring Agents (Dyes)IBA 01/2017
1	Insulin (Novolin)FDA Link 01/2017
1	Platelet Endothelial Cell Adhesion Molecule-1IBA 08/2014
1	Ion Channels (Ion Channel)IBA 05/2014
1	Hematoxylin (Haematoxylon)IBA 05/2014
1	Eosine Yellowish-(YS) (Eosin)IBA 05/2014
1	Aquaporin 5IBA 05/2014
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2014
1	Interleukin-8 (Interleukin 8)IBA 04/2014
1	Culture MediaIBA 04/2014
1	Interleukin-17 (Interleukin 17)IBA 04/2014
1	CopperIBA 02/2013
1	Saline SolutionIBA 11/2012
1	SteroidsIBA 11/2012
1	CelluloseIBA 11/2012
1	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2012
1	pimonidazoleIBA 06/2012
1	Isoniazid (Ftivazide)FDA LinkGeneric 02/2012
1	MannosidesIBA 01/2012
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2012
1	EnzymesIBA 01/2012
1	Nonesterified Fatty Acids (NEFA)IBA 01/2012
1	Scavenger Receptors (Scavenger Receptor)IBA 01/2012
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2012
1	oxidized low density lipoproteinIBA 01/2012
1	SolutionsIBA 01/2012
1	Sucrose (Saccharose)IBA 01/2012
1	Tryptophan (L-Tryptophan)FDA Link 01/2012
1	Blood Glucose (Blood Sugar)IBA 01/2012
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2012

Therapy/Procedure

7	Drug Therapy (Chemotherapy) 01/2017 - 09/2007
5	Therapeutics 10/2018 - 09/2007
1	Aftercare (After-Treatment) 01/2017
1	Debridement 11/2012
1	Combination Drug Therapy (Combination Chemotherapy) 02/2012